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Abstract. 
 
In this study we present evidence about the 
cellular functions of KIF4. Using subcellular fraction-
ation techniques and immunoisolation, we have now 
identiﬁed a type of vesicle that associates with KIF4, an 
 
NH
 
2
 
-terminal globular motor domain kinesin-like pro-
tein. This vesicle is highly concentrated in growth cones 
and contains L1, a cell adhesion molecule implicated in 
axonal elongation. It lacks synaptic vesicle markers, re-
ceptors for neurotrophins, and membrane proteins in-
volved in growth cone guidance. In cultured neurons, 
KIF4 and L1 predominantly localize to the axonal shaft 
and its growth cone. Suppression of KIF4 with anti-
sense oligonucleotides results in the accumulation of L1 
within the cell body and in its complete disappearance 
from axonal tips. In addition, KIF4 suppression pre-
vents L1-enhanced axonal elongation. Taken collec-
tively, our results suggest an important role for KIF4 
during neuronal development, a phenomenon which 
may be related to the anterograde transport of L1-con-
taining vesicles.
Key words: KIF4 • L1-glycoprotein • microtubule-
based transport • axons • neuronal polarity
 
Introduction
 
During recent years a growing body of genetic, molecu-
lar biological, and immunological data has emerged sug-
gesting that kinesin (Brady, 1985; Vale et al., 1985) and
 
kinesin-like proteins (KLPs)
 
1
 
 (Hirokawa et al., 1998;
Hirokawa, 1999) are microtubule-based motor proteins
specialized in the transport of membrane-bound or-
ganelles. The large number of KLPs identified in neurons
(Hirokawa, 1999) can provide multiple possibilities for
cargo selectivity, an event that is likely to be essential for
generating the highly polarized distribution of the cyto-
plasmic and membrane components that distinguishes the
axonal and somatodendritic domains of mature neurons.
The identification of the type of cargo that each KLP
translocates is therefore a key step for elucidating their
functional involvement in the development and mainte-
nance of neuronal polarity. Examples of KLPs with identi-
fied cargos include KIF1A, which transports synaptic vesi-
cles precursors along axons (Okada et al., 1995), KIF2,
which associates with nonsynaptic vesicles containing the
insulin-like growth factor receptor 
 
b
 
gc (Morfini et al.,
1997), and KIFC2, which appears to transport a class of
multivesicular body in dendrites (Hanlon et al., 1997; Saito
et al., 1997). In neurons, the cargos transported by all
other KLPs remain largely unknown.
KIF4 is a 1,231–amino acid KLP composed of an NH
 
2
 
-
terminal globular motor domain, a central 
 
a
 
-helical stalk
domain, and a COOH-terminal tail domain. KIF4 forms a
homodimer that moves along microtubules towards the
plus-end at a velocity of 0.2 
 
m
 
m/s (Sekine et al., 1994; Hi-
rokawa et al., 1998; Hirokawa, 1999). KIF4 is predomi-
nantly expressed in juvenile tissues, including developing
neurons, where it associates with a population of small
membranous organelles localized to neurites and growth
cones (Sekine et al., 1994). Based on these observations, it
has been suggested that KIF4 is a unique anterograde mo-
tor that transports specific organelles involved in nerve
cell morphogenesis (Sekine et al., 1994).
To test this hypothesis, in this study we have used a
combination of biochemical, immunological, and antisense
experiments to characterize the cargo transported by
KIF4. The results obtained suggest an important role for
KIF4 in neuronal morphogenesis, a phenomenon which
appears to be related with the anterograde transport of a
type of nonsynaptic vesicle that contains as one of its com-
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ponents the cell adhesion molecule L1, a protein involved
in axonal formation, fasciculation, and guidance (Walsh
and Doherty, 1997; Kamiguchi et al., 1998).
 
Materials and Methods
 
Cell Culture
 
Dissociated cultures of hippocampal pyramidal cells from embryonic rat
brain tissue were prepared as described previously (Cáceres et al., 1986;
Mascotti et al., 1997). Cells were plated onto polylysine-coated glass cov-
erslips (12 or 25 mm in diameter) at densities ranging from 5,000–15,000
cells/cm
 
2
 
 and maintained with DME plus 10% horse serum for 2 h. The
coverslips with the attached cells were then transferred to 60-mm petri
dishes containing serum-free medium plus the N2 mixture of Bottenstein
and Sato (1979). All cultures were maintained in a humidified 37
 
8
 
C incu-
bator with 5% CO
 
2
 
. For some experiments, an L1-Fc chimera (a generous
gift of Dr. Sue Kenwrick, University of Cambridge, Cambridge, UK) con-
sisting of the Fc region of human Ig and essentially the whole extracellular
domain of human L1 (see Doherty et al., 1995) was directly added to the
medium of hippocampal cell cultures at a concentration of 5 
 
m
 
g/ml.
 
Antisense Oligonucleotides
 
Two KIF4 antisense phosphorothioate oligonucleotides (S-modified)
were used in this study. One of them, designated ASKIF4a, corresponds
to the sequence ACTTGAGTGTCTGCTTC and is the inverse comple-
ment of nucleotides 
 
1
 
2211/2227 of the sequence of mouse KIF4; antisense
oligonucleotide ASKIF4b consisting of the sequence TGGTTCTGATG-
GCGGTTC is the inverse complement of the mouse nucleotides 
 
1
 
4085/
5002. An L1 antisense oligonucleotide was also used in some experiments.
It corresponds to the sequence AGACTGTCATCACTGCCTA and is
the inverse complement of nucleotides 
 
1
 
3699/3717 of the sequence of rat
L1. The oligonucleotides were purified by reverse chromatography and
taken up in serum-free medium as described previously (Morfini et al.,
1997). For all the experiments, the antisense oligonucleotides were prein-
cubated with 2 
 
m
 
l of Lipofectin reagent (1 mg/ml; GIBCO BRL) diluted in
100 
 
m
 
l of serum-free medium. The resulting oligonucleotide suspension
was then added to the cultured cells at concentrations ranging from 1–5 
 
m
 
M.
Control cultures were treated with the same concentration of the corre-
sponding sense-strand oligonucleotides. For some experiments, hippo-
campal pyramidal cells were treated for 1 d with an S-modified KIF2 anti-
sense oligonucleotide (Morfini et al., 1997) in order to suppress KIF2
expression. The administration of all oligonucleotides was as follows: the
oligonucleotides were added to the culture medium 4 h after plating with
Lipofectin; the medium was then supplemented with additional oligonu-
cleotide without Lipofectin every 12 h until the end of the experiment.
 
Primary Antibodies
 
The following primary antibodies were used in this study: a mAb against
tyrosinated 
 
a
 
-tubulin (clone TUB-1A2, mouse Ig; Sigma Chemical Co.)
diluted 1:2,000; a mAb against 
 
b
 
-tubulin (mouse Ig; Sigma Chemical Co.);
a mAb against conventional kinesin heavy chain (uKHC) (clone H2, Pfis-
ter et al., 1989; a generous gift of Dr. Scott Brady, University of Texas,
Dallas) diluted 1:50; a rabbit polyclonal antibody against 
 
a
 
- and 
 
b
 
-tubulin
(Sigma Chemical Co.) diluted 1:100; a mAb against syntaxin (Transduc-
tion Laboratories) diluted 1:100; a mAb against a 151–amino acid peptide
mapping at the NH
 
2
 
 terminus of synaptotagmin (clone 41; Transduction
Laboratories) diluted 1:100; a mAb against a 270–amino acid peptide
mapping at the NH
 
2
 
 terminus of the human L1 molecule (clone 17; Trans-
duction Laboratories) diluted 1:100; an affinity-purified rabbit polyclonal
antibody against the cytoplasmic domain of chick L1 (a generous gift of
Dr. Vance Lemmon, Case Western Reserve University, Cleveland, OH;
see Lemmon and McLoon, 1986) diluted 1:250; an affinity-purified rabbit
polyclonal antibody against a 27.5-kD protein fragment corresponding to
amino acids 170–241 of human TAX-1 (Transduction Laboratories) di-
luted 1:100; a mAb against the amyloid precursor protein (APP) (Boeh-
ringer Mannheim) diluted 1:50; a mAb against DCC (for deleted in co-
lorectal carcinoma) (clone Ab-1; Oncogene Research Products) diluted
1:100; an affinity-purified goat polyclonal antibody against a peptide cor-
responding to an amino acid sequence mapping at the COOH terminus of
the semaphorin precursor (Santa Cruz Biotechnology) diluted 1:100; and
an affinity-purified rabbit polyclonal antibody against 
 
b
 
gc (Quiroga et al.,
 
1995; Mascotti et al., 1997) diluted 1:100. In addition, two affinity-purified
rabbit peptide antibodies against KIF4 were generated (Research Genet-
ics). One peptide corresponds to amino acid residues 396–406 of mouse
KIF4 (AKIF4), whereas the other corresponds to amino acids 123–135 of
mouse KIF4 (BKIF4).
 
Western Blot Analysis
 
Equal amounts of crude brain homogenates or whole cell extracts from
cultured hippocampal pyramidal cells were fractionated on 7.5% SDS-
PAGE and transferred to polyvinylidene difluoride (PVDF) membranes
in a Tris-glycine buffer, 20% methanol. The filters were dried, washed
several times with TBS (10 mM Tris, pH 7.5, 150 mM NaCl), and blocked
for 1 h in TBS containing 5% BSA. The filters were incubated for 1 h at
37
 
8
 
C with the primary antibodies in TBS containing 5% BSA. The filters
were then washed three times (10 min each) in TBS containing 0.05%
Tween 20, and incubated with a secondary HRP-conjugated antibody
(Promega Corporation) for 1 h at 37
 
8
 
C. After five washes with TBS and
0.05% Tween 20, the blots were developed using a chemiluminescence de-
tection system.
 
Preparation of Microtubules from Cytosolic Fractions
 
For some experiments, microtubules were prepared from cytosolic frac-
tions obtained from the cerebral cortex of 7-d-old rats by the method of
Vallee (1982) in the presence or absence of AMP-PNP. The association of
KIF4 with microtubules was then evaluated by Western blotting of the mi-
crotubule pellet using the anti-KIF4 antibodies.
 
Subcellular Fractionation and Sucrose Density 
Gradient Centrifugation
 
Multiple fractions from 3-d-old rat cerebral cortex were prepared as de-
scribed previously (Morfini et al., 1997). In brief, rat cerebral cortex was
gently homogenized with 10 vol of ice-cold 0.32 M sucrose, 10 mM Hepes,
pH 7.4. The homogenate was centrifuged at low speed (3,000 
 
g
 
) for 10 min
at 4
 
8
 
C. The supernatant was centrifuged at medium speed (9,200 
 
g
 
) for
15 min. The medium speed supernatant was again centrifuged at high
speed (100,000 
 
g
 
) for 60 min to yield a cytosolic fraction (S3) and a mi-
crosomal one (P3). All the obtained fractions (supernatants and pellets)
were then subjected to electrophoresis, transferred to PVDF membranes,
and probed with the AKIF4 antibody. For some experiments, the mi-
crosomal fraction was further applied to either a discontinous sucrose
density gradient (SDG) (0.4, 0.8, 1.2 M) or to a continuous one (0.3–1.6 or
1.0–2.0 M) at 48,000 rpm for 2 h in a Sorvall STS 60.4 rotor. Fractions were
then collected from 4-ml tubes. They were then centrifuged at 100,000 
 
g
 
,
and the resulting pellets resuspended in Laemmli buffer. The same vol-
ume from each fraction was applied to SDS-PAGE and transferred to
PVDF membrane. Fractions were then analyzed by immunoblotting with
antibodies against uKHC, KIF2, KIF4, synaptic vesicle markers, and
growth cone membrane components.
 
Isolation of Growth Cone Particles (GCPs) by 
Subcellular Fractionation
 
Fetal rat brain (18 d of gestation) was fractionated according to Pfen-
ninger et al. (1983) (see also Quiroga et al., 1995) to obtain GCPs. In brief,
the low-speed supernatant (L) of fetal brain homogenate (H) was loaded
on a discontinuous sucrose gradient in which the 0.75 and 1 M sucrose lay-
ers were replaced with a single 0.83-M sucrose step. This facilitated collec-
tion of the interface and increased GCP yield without decreasing purity
(Paglini et al., 1998). The 0.32–0.83 M interface or A fraction was col-
lected, diluted with 0.32 M sucrose, and pelleted to give the GCP fraction.
This was resuspended in 0.32 M sucrose for experimentation. It is worth
noting that this preparation (GCPs) has been extensively characterized by
electron microscopic (Pfenniger et al., 1983; Li et al., 1992) and biochemi-
cal methods. These studies have revealed that GCPs contain significant
amounts of c-src, tau, GAP-43 (Lohse et al., 1996), and 
 
b
 
gc (Quiroga et al.,
1995), but lack detectable amounts of high molecular weight MAP2, glial
fibrillar acidic protein, and vimentin (Lohse et al., 1996).
 
Immunoisolation of KIF4-containing Organelles
 
Immunoisolation of KIF4-containing organelles was performed as de-
scribed by Morfini et al. (1997) (see also Okada et al., 1995). For this ex- 
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periment, the AKIF4 antibody or the antibody against the cytoplasmic do-
main of chick L1 was covalently attached to protein A–Sepharose beads
(Morfini et al., 1997). Microsomal fractions were incubated with these
beads at 4
 
8
 
C for 6 h, and the beads were recovered by centrifugation
(5,000 rpm for 120 s), and washed with 20 mM Hepes, 100 mM K-aspar-
tate, 40 mM KCl, 5 mM EGTA, 5 mM MgCl
 
2
 
, 2 mM Mg-ATP, 1 mM
DTT, pH 7.2, supplemented with several protease inhibitors. The super-
natant was spun down (75,000 rpm for 30 min) to collect the remaining or-
ganelles. Immunoblotting was then performed as described previously
with antibodies against uKHC, KIF2, KIF4, L1, TAX-1, and synapto-
tagmin.
 
Immunofluorescence
 
Cells were fixed before detergent extraction and processed for immuno-
fluorescence as described previously (Paglini et al., 1998). The antibody
staining protocol entailed labeling with the first primary antibody, wash-
ing with PBS, staining with labeled secondary antibody (fluorescein or
rhodamine conjugated), and washing similarly. The same procedure was
repeated for the second primary antibody. Incubations with primary anti-
bodies were for 1 or 3 h at room temperature, whereas incubations with
secondary antibodies were performed for 1 h at 37
 
8
 
C. The cells were ob-
served with an inverted microscope (Carl Zeiss Axiovert 35M) equipped
with epifluorescence and differential interference contrast (DIC) optics.
Fluorescent images were captured under regular fluorescence microscopy
with a silicon-intensified target camera (SIT-C2400; Hamamatsu Corp.).
The images were digitized directly into a Metamorph/Metafluor Image
Processor (Universal Imaging Corp.). Fluorescence intensity measure-
ments were performed pixel-by-pixel along the longitudinal axis of identi-
fied neurons (Paglini et al., 1998). Using this data, we then calculated the
average fluorescence intensity within the cell body, the distal third of
identified neurites (either minor processes or axons), and the central re-
gion of growth cones. Photographs were printed using Adobe Photoshop.
To measure neuronal shape parameters, fixed unstained or antibody-
labeled cells were randomly selected and traced from a video screen using
the morphometric menu of the Metamorph as described previously
(Cáceres et al., 1992; Morfini et al., 1997). Differences among groups were
analyzed by the use of ANOVA and Student-Newman Keul’s test.
 
Results
 
Characterization of a Peptide Antibody against KIF4
 
The monospecificity of the affinity-purified rabbit poly-
clonal antibody designated AKIF4 raised against a peptide
corresponding to amino acid residues 396–406 of mouse
KIF4 is shown in Fig. 1 A. This antibody recognizes a sin-
gle band of 
 
z
 
140,000 
 
M
 
r
 
 in Western blots of whole cell ho-
mogenates from the cerebral cortex of developing rats
(Fig. 1 A, lanes 1 and 2). The staining generated by this an-
tibody is completely abolished by neutralization with the
corresponding purified peptide (Fig. 1 A, lane 3).
Fig. 1 B shows that in the cerebral cortex, the expression
of the AKIF4 immunoreactive protein species is higher at
early postnatal days, declining gradually but considerably
until adulthood, where the lowest levels are detected. In
addition, Western blot analysis of subcellular fractions
obtained from the cortex of 3-d-old rats revealed that the
140-kD protein is relatively concentrated in the microso-
mal fraction compared with the cytosol or the mitochon-
drial fraction (Fig. 1 C). This means that a considerable
amount of the protein recognized by the AKIF4 antibody
is associated with small membranous organelles, but only
barely associated with larger ones such as mitochondria
(Fig. 1 C). Besides, microtubule binding experiments show
that in the absence of ATP the 140-kD protein cosedi-
ments with taxol-stabilized microtubules obtained from
the cerebral cortex; this binding occurs in the presence or
absence of AMP-PNP (data not shown). Since all the
above described properties are identical to those reported
previously for KIF4 (see Sekine et al., 1994), we conclude
that this antibody effectively recognizes KIF4 and not a
different protein having a similar molecular weight.
 
Biochemical Evidences for the Association of KIF4 with 
L1-containing Vesicles
 
To begin analyzing the type of cargo that KIF4 may trans-
port, microsomal fractions from rat cerebral cortex were
fractionated by isopicnic SDG centrifugation and analyzed
by immunoblotting with antibodies against uKHC, KIF2,
KIF4, and several membrane proteins, including synaptic
and nonsynaptic vesicle constituents. This type of ap-
proach has already proven useful to identify the type of
membrane-bound organelle associated with KIF1A and
KIF2 (Okada et al., 1995; Morfini et al., 1997).
Approximately 70–80% of uKHC, KIF2, or KIF4 was
recovered in the P3 (high-speed pellet) fraction, whereas
 
,
 
30% was present in the P2 (medium-speed fraction) and
S3 (high-speed supernatant) fractions. When the P3 mi-
crosomal fraction was applied to a discontinuous gradient
of 0.4, 0.8, and 1.2 M sucrose (see Materials and Methods),
fractions with a very different molecular composition were
obtained (Fig. 2, A–C). In this gradient, uKHC and KIF2
were recovered in the 0.4- and 0.8-M fractions (Fig. 2 A).
In contrast, KIF4 was predominantly recovered in the
1.2-M sucrose fraction (Fig. 2 A). The distribution of KIF4
was then compared with that of synaptotagmin, a constitu-
ent of the synaptic vesicle precursor that is transported by
KIF1A (Okada et al., 1995), and syntaxin, a presynaptic
Figure 1. (A) Specificity of the
affinity-purified peptide anti-
body against KIF4 (AKIF4) as
revealed by Western blot analy-
sis of whole tissue extracts ob-
tained from the cerebral cortex
of 3-d-old rats. The AKIF4 anti-
body (diluted 1:100) stains a sin-
gle immunoreactive protein spe-
cies with an apparent molecular
weight of 140 kD (lanes 1 and 2).
The staining generated by this
antibody is completely abolished
by neutralization with the corre-
sponding purified peptide (lane
3). 10 mg of total protein was
loaded in lane 1, and 20 mg in
lanes 2 and 3. Lane 4 shows an equivalent sample to that of lane
1, but revealed with a mAb against uKHC. (B) The expression of
KIF4 in the developing rat cerebral cortex as revealed by immu-
noblot analysis of whole tissue extracts. E18, embryonic day 18;
P5–P15, postnatal days 5–15; Ad, adult. KIF4 is highly expressed
in the developing cerebral cortex. The blot was reacted with
AKIF4 antibody (dilution 1:100); 20 mg of total protein was
loaded in each lane. (C) Western blot analysis of subcellular frac-
tions obtained from the cerebral cortex of 3-d-old rats showing
that KIF4 is enriched in the microsomal fraction (P3). S1, low-
speed supernatant; P1, pellet 1; S2, medium speed supernatant;
P2, pellet 2; S3, high-speed supernatant; P3, pellet 3 or microso-
mal fraction. The blot was reacted with AKIF4 (dilution 1:200);
20 mg of protein were loaded in each lane. 
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membrane protein absent from the KIF1A cargo (Okada
et al., 1995). The results obtained showed that neither
synaptotagmin nor syntaxin colocalizes with KIF4; both
types of synaptic vesicle proteins were enriched in the 0.4-
and 0.8-M sucrose fractions, but almost absent from the
heavier fraction that contains KIF4 (Fig. 2 A).
We next compared the distribution of KIF4 with that of
several well-characterized nonsynaptic membrane compo-
Figure 2. (A) The binding of
KIF4 to membrane vesicles.
Microsome fraction from de-
veloping rat cerebral cortex
was fractionated by centrifu-
gation across a discontinuous
SDG and the same volume
from each fraction was ap-
plied to SDS-PAGE, stained
with Coomassie blue (CB),
or transferred to PVDF
membranes and analyzed by
immunoblotting with anti-
bodies against uKHC, KIF2,
KIF4, synaptotagmin (p65),
syntaxin (SYNTX), L1,
TAX-1,  bgc, semaphorin III
(SEMA III), and DCC. Note
that KIF4 and L1 are en-
riched in the 1.2-M sucrose
fraction. (B and C) A similar
analysis to that shown in A,
but for a microsome prepara-
tion separated across a con-
tinuous SDG extending from
0.32–1.6 M (B) or 1.0–2.0 M
(C) sucrose. Note that KIF4
and L1 are enriched in frac-
tions extending from 1.2–
1.6 M sucrose. (D) Western
blot of total brain homoge-
nate (H), fraction A (A), and
GCP reacted with antibodies
against uKHC, KIF4, and L1.
All antibodies were used at a
concentration of 0.5 mg/ml.
All fractions were obtained
from E18 rat embryos as de-
scribed in Materials and
Methods. 20 mg of total cellu-
lar protein was loaded in
each lane. Note that KIF4
and L1 are enriched in the
GCP fraction. (E) L1 (KIF4):
immunoisolation of L1-con-
taining organelles with the
AKIF4 antibody (dilution
1:50). Microsome fraction in-
cubated with AKIF4 preim-
mune serum: remanent or-
ganelles (lane 1) and
immunoprecipitated organelles (lane 2). Microsome fraction incubated with the AKIF4 antibody: remanent organelles (lane 3) and im-
munoprecipitated organelles (lane 4). Note that L1 is quantitatively recovered in this fraction. uKHC and TAX-1: equivalent fractions
to those show for L1, but reacted with antibodies against uKHC or TAX-1. Note that both proteins are predominantly recovered in the
remanent organelle fraction. KIF4 (L1): immunoisolation of KIF4-containing organelles with an antibody against the cytoplasmic do-
main of L1. Microsome fraction incubated with nonimmune serum: remanent organelles (lane 1) and immunoprecipitated organelles
(lane 2). Microsome fraction incubated with the anti-L1 rabbit polyclonal antibody: remanent organelles (lane 3) and immunoprecipi-
tated organelles (lane 4). Note that KIF4 is quantitatively recovered in this fraction. L1 (KIF2): failure of a rabbit polyclonal antibody
against KIF2 (BKIF2, diluted 1:50) to immunoprecipitate L1-containing vesicles. Microsome fraction incubated with nonimmune se-
rum: remanent organelles (lane 1) and immunoprecipitated organelles (lane 2). Microsome fraction incubated with the BKIF2 anti-
body: remanent organelles (lane 3) and immunoprecipitated organelles (lane 4). 
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nents. One of them, the cell adhesion molecule L1, a trans-
membrane protein belonging to the Ig superfamily that is
highly expressed in developing neurons (Moos et al.,
1988), displayed a striking codistribution with KIF4, being
highly enriched in the 1.2-M sucrose fraction (Fig. 2 A).
On the other hand, TAX-1, the human homologue of rat
axonin-1 which is another neuronal cell adhesion molecule
belonging to the Ig superfamily (Hasler et al., 1993), dis-
tributed in all fractions of the sucrose gradient with the
lowest levels detected in the 1.2-M sucrose fraction (Fig. 2
A). The patterns of distribution of 
 
b
 
gc, which is a novel
variant of the 
 
b
 
-subunit of the IGF-1 receptor, highly en-
riched in growth cone membranes and in vesicles that as-
sociate with KIF2 (Quiroga et al., 1995; Mascotti et al.,
1997; Morfini et al., 1997), as well as of several membrane
proteins involved in growth cone guidance, including
semaphorin III (Messeramith et al., 1995) and the netrin
receptor DCC (de la Torre et al., 1997), were all different
from that of KIF4 or L1 (Fig. 2 A). The codistribution of
KIF4 and L1 was further confirmed by Western blot anal-
ysis of microsomal fractions separated across a continuous
SDG extending from 0.3–1.6 M sucrose (Fig. 2 B). This
analysis revealed that both proteins were highly enriched
in fractions extending from 1.0–1.6 M sucrose, whereas
uKHC (Fig. 2 B), synaptotagmin (Fig. 2 B), syntaxin (data
not shown), or TAX-1 (Fig. 2 B) were all enriched in
lighter fractions. Finally, and to discard the possibility that
the localization of KIF4 with L1 at the bottom of the 0.3–
1.6 M sucrose gradient may represent copelleting rather
than actual association at a particular density, the distribu-
tion of both proteins was analyzed across a gradient ex-
tending from 1.0–2.0 M sucrose. Fig. 2 C shows that both
proteins colocalize in fractions extending from 1.2–1.6 M
sucrose, but are absent from heavier ones.
Since previous immunofluorescence studies have shown
that KIF4 (Sekine et al., 1994) and L1 (Kamiguchi and
Lemmon, 1998) are present at neuritic tips, it became of
interest to analyze their distribution in growth cone frac-
tions isolated by subcellular fractionation according to the
procedures described (Pfenninger et al., 1983; Paglini et al.,
1998; see also Materials and Methods). This analysis re-
vealed that KIF4 and L1 were not only present but also
enriched in GCPs when compared with the levels detected
in the total brain homogenate fraction or the A fraction
that contains cytosolic soluble proteins and GCPs. In con-
trast, no such enrichment was detected for uKHC (Fig. 2 D).
Taken together, these observations raise the possibility
of KIF4 interacting with a type of nonsynaptic vesicle that
accumulates in growth cones that is distinct from those in-
teracting with KIF2 (e.g., 
 
b
 
gc-containing nonsynaptic vesi-
cles), and that contains the cell adhesion molecule L1 as
one of its components. Therefore, to directly test this pos-
sibility, immunoisolation of organelles from the microso-
mal fraction was performed with the AKIF4 antibody or
with a rabbit polyclonal antibody directed against the cy-
toplasmic domain of L1. The remaining organelles were
recovered by pelleting from the supernatant fraction. Fig.
2 E shows that with this method, the KIF4-containing or-
ganelles were collected. More importantly, in this immu-
noisolated organelle fraction both KIF4 and L1 were
quantitatively recovered. By contrast, uKHC (Fig. 2 E),
KIF2 (not shown), synaptotagmin (not shown), or TAX-1
 
(Fig. 2 E) were not, or were only slightly detectable in this
fraction; they were quantitatively recovered in the remain-
ing organelle fraction. In addition, they were not detected
in the supernatant fraction after pelleting the remaining
organelles, effectively ruling out the possibility that the
lack of these proteins in the KIF4/L1 organelle-contain-
ing fraction was due to dissociation during the immuno-
isolation procedure. Finally, it is worth mentioning that
we failed to immunoisolate L1-containing vesicles with
BKIF2 (Fig. 2 E), a rabbit polyclonal antibody against
KIF2 previously used to coprecipitate 
 
b
 
gc-containing vesi-
cles (see Morfini et al., 1997).
These results clearly and directly demonstrate that KIF4
is associated with a class of nonsynaptic membranous or-
ganelle that contains L1 as one of its components. How-
ever, they do not provide evidence about the in vivo rela-
tionship between KIF4 and the transport of L1-containing
organelles, and/or the functional role of KIF4 during neu-
ronal morphogenesis. Therefore, to obtain evidence about
these aspects, we decided to examine the subcellular distri-
bution of KIF4 as well as the consequences of its suppres-
sion on the distribution of L1 in cultured hippocampal py-
ramidal neurons. In this cell system, endogenous L1 and
virally expressed NgCAM (the chick homologue of L1),
but not several other axonal membrane proteins, become
restricted to the axonal domain at early stages of morpho-
logical polarization (Jareb and Banker, 1998; Kamiguchi
and Lemmon, 1998; Stowell and Craig, 1999), thus provid-
ing an excellent opportunity to test whether or not antero-
grade microtubule-based molecular motors such as KIF4
participate in neuronal polarization.
 
The Subcellular Distribution of KIF4 in Cultured 
Hippocampal Pyramidal Neurons
 
Cultured hippocampal pyramidal neurons have proven to
be an excellent model system for studying growth cone
formation, neurite outgrowth, the establishment of neu-
ronal polarity, as well as the expression and function of cy-
toskeletal and membrane proteins involved in nerve cell
morphogenesis (Craig and Banker, 1994; Bradke and
Dotti, 1997, 1999; Jareb and Banker, 1998; Paglini et al.,
1998; Stowell and Craig, 1999). Since protein localization
can be examined with the least ambiguity in young neu-
rons before an extensive axonal network develops (see
Jareb and Banker, 1998), we examined the subcellular dis-
tribution of KIF4 48 h after cell plating, when neurons
had become polarized (stage III neurons; see Craig and
Banker, 1994) and the axon could be readily distinguished
from the remaining minor neurites that will later develop
as dendrites. Double immunofluorescence staining of
these cells with the AKIF4 antibody and with a mAb
against tyrosinated 
 
a
 
-tubulin or a mAb against 
 
b
 
-tubulin
revealed that KIF4 immunolabeling is preferentially local-
ized to the cell body and the distal third of the growing
axon, including its growth cone, where the highest immuno-
fluorescence signal is detected (Fig. 3, A–D). In contrast,
minor neurites and/or their growth cones exhibit little if
any staining at all. To test whether or not this distribu-
tional pattern represents a property common to other
NH
 
2
 
-terminal type microtubule-based motors, the subcel-
lular localization of uKHC was also analyzed in stage III 
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hippocampal pyramidal neurons. The results showed that
uKHC displays a widespread distribution, localizing in ax-
ons and minor processes. In addition, this analysis re-
vealed that uKHC immunofluorescence was not particu-
larly prominent at the distal end of growing axons or in
growth cones (Fig. 3, E and F). In a complementary series
of experiments, we used quantitative fluorescence tech-
niques to measure the relative amounts of KIF4 and
uKHC in axons, minor neurites, and growth cones of stage
III hippocampal pyramidal neurons. The results obtained,
which are shown in Table I, confirm our observations and
clearly establish that KIF4 immunolabeling is preferen-
tially localized to axonal processes and their growth cones.
 
Antisense Oligonucleotides Inhibit KIF4 Expression 
and Alter the Distribution of L1
 
Two phosphorothioate (S-modified) antisense oligonucle-
otides were tested for their ability to inhibit KIF4 expres-
sion. Cultured hippocampal pyramidal cells incubated for
24 h with different doses (2.5 or 5 
 
m
 
M) of the ASKIF4a an-
Figure 3. The subcellular distribution of KIF4 in cultured hip-
pocampal pyramidal neurons. (A and B) Double immunofluores-
cence micrograph showing the distribution of KIF4 (A) and tyro-
sinated a-tubulin in a stage III hippocampal pyramidal cell. Note
that KIF4 immunofluorescence predominantly localizes to the
axon and its growth cone (long arrow). Light KIF4 immunolabel-
ing is also detected in the growth cones (short arrow) of some mi-
nor processes. For this experiment the AKIF4 was diluted 1:100.
(C and D) Double immunofluorescence micrographs showing
the distribution of KIF4 and b-tubulin in a stage III hippocampal
pyramidal cell. In this case the AKIF4 antibody was diluted 1:50.
As shown previously, KIF4 immunolabeling preferentially local-
izes to axons and their growth cones (long arrows). A light immu-
nofluorescence signal is also detected in minor processes. (E and
F) Double immunofluorescence micrographs showing the distri-
bution of uKHC (E) and total tubulin (F) in a stage III hippo-
campal pyramidal cell. Note that uKHC immunolabeling has a
widespread distribution localizing to both axons and minor pro-
cesses. Bar, 10 mm.
Figure 4. Antisense oligonucleotides inhibit KIF4 expression.
(A) Western blot showing the effect of the ASKIF4a antisense
oligonucleotides on KIF4 and b-tubulin (TUB) protein levels.
Lane 1, control nontreated; lane 2, sense-treated (5 mM); lane 3,
ASKF4a-treated (2.5 mM); and lane 4, ASKIF4a-treated (5 mM).
The Western blot was revealed with the AKIF4 antibody (diluted
1:100) and a mAb against b-tubulin. (B) Western blot showing
the effect of the ASKIF4b antisense oligonucleotide on KIF4
protein levels as revealed by the use of the BKIF4 antibody (di-
luted 1:100). Lane 1, sense-treated (5 mM); and lane 2, ASKIF4b-
treated (5 mM). Note that the ASKIF4b antisense oligonucle-
otide selectively decreases KIF4 protein levels without affecting
the BKIF4 immunoreactive protein band migrating at the posi-
tion of tubulin (55 kD). (C) Effect of the ASKIF4a antisense oli-
gonucleotide on uKHC, L1, bgc, or APP protein levels. Lanes 1,
3, 5, and 7, sense-treated (5 mM); lanes 2, 4, 6, and 8, ASKIF4a-
treated (5 mM). For these experiments, cultures were treated for
1 d with sense or antisense oligonucleotides, starting 4 h after
plating. 25 mg of total cellular protein was loaded in each lane. 
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tisense oligonucleotide described in Materials and Meth-
ods showed markedly reduced reactivity to the AKIF4 an-
tibody, as assessed by Western blotting of whole cell
extracts (Fig. 4 A). In contrast, cells treated with sense oli-
gonucleotides are comparable in their immunoreactivity
to untreated control cells (Fig. 4 A). The ability of the
ASKIF4b antisense oligonucleotide (5 
 
m
 
M) to decrease
KIF4 protein levels was also evaluated using a different
KIF4 antibody. This affinity-purified rabbit polyclonal an-
tibody, designated BKIF4, raised against a peptide corre-
sponding to amino acid residues 122–134 of mouse KIF4,
recognizes a 140-kD protein band (Fig. 4 B, lane 1) and
also a protein migrating at the position of tubulin. As
shown in Fig. 4 B, the BKIF4 immunolabeling of the 140-kD
protein band selectively decreases in whole cell extracts
obtained from ASKIF4b-treated cultures (Fig. 4 B, lane
2). No such a decrease is observed with respect to the pro-
tein band migrating at the position of tubulin. Our results
also show that the ASKIF4a antisense oligonucleotide
does not affect tubulin expression as revealed by labeling
with a mAb against 
 
b
 
-tubulin (Fig. 4 A, lanes 1–4), or the
one of uKHC (Fig. 4 B), KIF2 (data not shown), L1 (Fig. 4
B), 
 
b
 
gc (Fig. 4 B), or the APP (Fig. 4 B). The presence of
normal levels of these proteins in the KIF4-suppressed
cells suggests that the effect of the antisense treatment is
specific and that the regulation of the expression of other
proteins, including microtubule-based motors, is indepen-
dent of KIF4.
Next, we examined the distribution of L1 in control and
KIF4 antisense oligonucleotide-treated hippocampal pyra-
midal neurons. As expected, KIF4 immunofluorescence
was dramatically reduced in neurons treated with the anti-
sense oligonucleotides (Table II). In addition, a significant
alteration in the distribution of L1 was also detected (Fig.
5). Thus, whereas in 
 
.
 
90% of nontreated or sense-treated
hippocampal pyramidal neurons L1 is selectively and
highly enriched in axons and their growth cones (Fig. 5, A,
B, E, and F), in the KIF4 antisense-treated cells all of the
labeling is present within the cell body or the inner third of
the axonal shaft, being completely absent from axonal
growth cones (Fig. 5, C, D, and G–J; see also Table II). In
contrast, the distribution of several other membrane pro-
teins present in growth cones, such as 
 
b
 
gc transported by
KIF2 (Morfini et al., 1997) or APP transported by KHC
(Ferreira et al., 1993), was unaltered in the KIF4 anti-
sense-treated neurons (Fig. 6, A–D; see also Table II). To
determine if other KLPs may also be required for L1
transport, cells were treated with KIF2 antisense oligonu-
cleotides (Morfini et al., 1997). As shown in Fig. 6, E and
F, KIF2 suppression does not alter the distribution of L1.
However, and as described previously (Morfini et al.,
1997), this treatment produces a dramatic reduction of 
 
b
 
gc
immunolabeling at the growth cone and a concomitant ac-
cumulation within the cell body (see Table II). In addition,
and to obtain some evidence as to whether or not L1 may
be a single major component of the KIF4 cargo, the ex-
pression and distribution of KIF4 was analyzed in neurons
treated with an L1-antisense oligonucleotide. As shown in
Fig. 7 A, a dose-dependent reduction in L1 protein levels
was detected when cultures were exposed for 24 h to dif-
ferent concentrations of the L1-antisense oligonucleotide.
In contrast, no such a decrease was detected in cells
treated with equivalent doses of the corresponding sense-
strand oligonucleotide (data not shown). The results ob-
tained also show that L1 suppression has no effect on the
levels or distribution (Fig. 7, B and C) of KIF4 as might be
expected if other as-yet unidentified proteins are compo-
nents of the KIF4 cargo.
 
KIF4 Suppression Prevents L1-stimulated
Axonal Elongation
 
Previous studies have shown that purified L1 or an L1-Fc
 
Table I. Quantitative Measurements of KIF4 and uKHC Immunofluorescence in Cultured Hippocampal Pyramidal Cells
 
Cell body Axon
Axonal
growth cones Minor processes
Growth cones of
minor processes
 
Total tubulin 230 
 
6
 
 20 145 
 
6
 
 20 35 
 
6
 
 10 135 
 
6
 
 10 35 
 
6
 
 10
 
b
 
-Tubulin 220 
 
6 
 
25 140 
 
6
 
 15 30 
 
6
 
 5 135 
 
6
 
 20 48 
 
6
 
 10
KIF4 140 
 
6
 
 20 130 
 
6
 
 16 145 
 
6
 
 10 30 
 
6
 
 8 20 
 
6
 
 8
uKHC 180 
 
6
 
 15 120 
 
6
 
 20 55 
 
6
 
 10 120 
 
6
 
 20 40 
 
6
 
 10
 
Average fluorescence intensity measurements within the cell body, the distal third of the axon, the distal third of minor processes, and the central region of growth cones were per-
formed as described in the Materials and Methods section. Each value represents the mean 
 
6
 
 SEM. Pixel intensity expressed in gray values: 0 (black)/255 (white). Cells were dou-
ble labeled with a rabbit polyclonal antibody against 
 
a
 
- and 
 
b
 
-tubulin (Total tubulin) and a mAb against uKHC, or with a mAb against 
 
b
 
-tubulin and the AKIF4 antibody. A total
of 50 cells was measured for each double immunofluorescence.
 
Table II. Quantitative Measurements of KIF4, L1, and 
 
b
 
gc 
Immunofluorescence in Cultured Hippocampal Pyramidal 
Cells Treated with KIF4 and KIF2 Antisense Oligonucleotides
Cell body Axon Growth cone
Nontreated
KIF4 140 6 20 130 6 16 145 6 10
L1 80 6 10 95 6 10 125 6 12
bgc 110 6 15 75 6 10 85 6 15
KIF4 sense-treated (5 mM)
KIF4 145 6 15 120 6 20 145 6 10
L1 80 6 15 95 6 10 115 6 10
bgc 105 6 15 80 6 10 85 6 15
ASKIF4a-treated (5 mM)
KIF4 14 6 4 ND* ND*
L1 100 6 10 10 6 5* ND*
bgc 105 6 15 65 6 10 95 6 20
ASKIF2-treated (5 mM)
KIF4 140 6 20 125 6 10 140 6 10
L1 85 6 10 100 6 20 105 6 15
bgc 145 6 10 ND* ND*
Average fluorescence intensity measurements within the cell body, the distal third of
the axon, and the central region of axonal growth cones were performed as described
in the Materials and Methods section. Each value represents the mean 6 SEM. Pixel
intensity expressed in gray values: 0 (black)/255 (white). A total of 30 cells was mea-
sured for each experimental condition.
*Values significantly different from those of control cells (nontreated or sense-
treated). ND: not detectable.The Journal of Cell Biology, Volume 149, 2000 148
chimera can promote as a substrate bound molecule neu-
rite elongation in culture neurons (Lemmon et al., 1992;
Doherty et al., 1995). A similar effect has been observed
when using the L1-Fc chimera as a soluble molecule
(Doherty et al., 1995). Since this response appears to be
related with the homophilic binding of L1 in growth cones
to soluble L1 (Neugebauer et al., 1988; Seilheimer and
Schachner, 1988; Doherty et al., 1995), it became of inter-
est to test whether or not KIF4 suppression prevents L1-
stimulated axonal extension. For such a purpose, control
and ASKIF4a-treated 1-d-old hippocampal pyramidal cells
were cultured for an additional 24-h period in the presence
Figure 5. KIF4 suppression alters L1 subcellular localization. (A
and B) Double immunofluorescence micrographs showing the
distribution of L1 (A) and tyrosinated a-tubulin (B) in a stage III
hippocampal pyramidal cell. Note that L1 is preferentially local-
ized to the distal third of the axon and its growth cone (arrow).
(C and D) An equivalent cell to that shown previously but from a
culture treated with the ASKIF4a antisense oligonucleotide (5 mM).
Note that L1 immunofluorescence has disappeared from the
growth cone and the distal axon. (E and F) Double immunofluo-
rescence micrograph showing the distribution of L1 (E) and tyro-
sinated  a-tubulin (F) in another hippocampal pyramidal cell
from a control (sense-treated) culture. The cell that is at the tran-
sition of stage II to stage III displays strong L1 immunofluores-
cence in the longest neurite, the presumptive axon, and its
growth cone (arrows). (G and H) An equivalent cell to that
shown previously, but from a culture treated with the ASKIF4a
antisense oligonucleotide (5 mM). Note that L1 immunofluores-
cence (G) is exclusively localized to the cell body. (I and J) Dou-
ble immunofluorescence micrographs showing the distribution of
L1 (I) and tyrosinated a-tubulin (J) in a stage III hippocampal
pyramidal cell from a culture treated with the ASKIF4b (5 mM).
Note the dramatic decrease of L1 immunolabeling in the axon
and its growth cone. For these experiments, cells were treated
with sense or antisense oligonucleotides for 30 h, starting 4 h af-
ter plating. Bar, 10 mm.
Figure 6. (A and B) Double immunofluorescence micrographs
showing the distribution of tyrosinated a-tubulin and bgc in a
stage III hippocampal pyramidal cell from a culture treated with
the ASKIF4a antisense oligonucleotide (5 mM) for 24 h. Note
that bgc immunofluorescence is higher at the distal third of the
axon, including its growth cone (arrow). (C and D) Double im-
munofluorescence micrographs showing the distribution of tyro-
sinated a-tubulin and APP in a stage III hippocampal pyramidal
cell from a culture treated with the ASKIF4a antisense oligonu-
cleotide (5 mM) for 24 h. Note that within the axon APP, immuno-
fluorescence is preferentially localized at the growth cone (ar-
row). (E and F) Double immunofluorescence micrograph
showing the distribution of b-tubulin and L1 in a stage III hip-
pocampal pyramidal cell from a culture treated with a KIF2 anti-
sense oligonucleotide (5 mM). Note that L1 immunofluorescence
remains high within the axonal growth cone (arrow). Cultures
were treated with antisense oligonucleotides as described in the
previous figure. Bar, 10 mm.Peretti et al. KIF4 Function in Developing Neurons 149
of an L1-Fc chimera. The neurite outgrowth response was
then evaluated by morphometry of fixed cultures (Do-
herty et al., 1995; see also Materials and Methods). The
results obtained show that the addition of the L1-Fc
chimera to the tissue culture medium at a concentration of
5 mg/ml selectively increases axonal length in control and
sense-treated neurons (Fig. 8). On the other hand, KIF4
suppression completely inhibits L1-stimulated axonal elon-
gation without affecting either the length (Fig. 8) or the
number of minor processes. This effect appears to be
dependent on the presence of L1, since KIF4 suppression
has no effect on minor neurite formation and/or axonal
outgrowth in neurons growing on polylysine alone (Fig. 8).
Inhibition of L1-stimulated axonal elongation in KIF4 an-
tisense-treated neurons becomes evident 24 h after the ad-
dition of the antisense oligonucleotides, being highly coin-
cident with the reduction in KIF4 protein levels. When,
after 48 h in the presence of the antisense oligonucleotide,
the cells are released from antisense inhibition by chang-
ing the medium, axonal extension resumed at a rate equiv-
alent to that observed under control conditions. This phe-
nomenon is accompanied by reexpression of KIF4 and
appearance of L1 at axonal tips (Table III).
Discussion
KIF4 and the Subcellular Distribution of L1
These results confirm and extend previous observations by
Sekine et al. (1994) suggesting that KIF4 is an anterograde
microtubule-based motor involved in the transport of a
class of nonsynaptic membrane organelle abundant in de-
veloping neurons. The new information presented here
suggests that at least one of the components of the KIF4
cargo is the L1 glycoprotein, a cell adhesion molecule
present in axonal growth cones (Van den Pol and Kim,
1993; Jareb and Banker, 1998; Kamiguchi and Lem-
mon,  1998; this study) and implicated in promoting axonal
elongation (Neugebauer et al., 1988; Seilheimer and
Schachner, 1988; Doherty et al., 1995). Thus, one striking
finding in KIF4-suppressed hippocampal pyramidal neu-
rons is the altered distribution of L1. In untreated cells, or
cells treated with sense oligonucleotides, L1 is found selec-
tively concentrated within axonal shafts and their growth
cones. In antisense-treated cells, on the other hand, L1 is
confined to the cell body or the most proximal third of the
axon.
Several observations suggest that this effect is the result
of a specific and selective blockade of KIF4 expression
by the antisense treatment. First, sequence analysis of the
regions of the KIF4 mRNAs selected for designing the an-
tisense oligonucleotides reveals no significant homology
Figure 7. (A) Western blot showing the effect of an L1-antisense
oligonucleotide on L1 protein levels. Lane 1, sense-treated (5 mM);
lane 2, antisense-treated (1 mM); lane 3, antisense-treated (2.5 mM);
and lane 4, antisense-treated (5 mM). The Western blot was re-
vealed with the rabbit polyclonal antibody against the cytoplas-
mic domain of L1. For this experiment cultures were treated for 1 d
with sense or antisense oligonucleotides, starting 4 h after plat-
ing. 25 mg of total cellular protein was loaded in each lane. The
levels of L1 in sense-treated cultures were equivalent to those of
nontreated cells. (B and C) Double immunofluorescence micro-
graph showing the distribution of tyrosinated a-tubulin (B) and
KIF4 (C) in a stage III hippocampal pyramidal cell from a culture
treated with the L1 antisense oligonucleotide (5 mM). Note that
KIF4 immunofluorescence remains high within the axonal
growth cone. Bar, 10 mm.
Table III. The Inhibitory Effect of KIF4 Antisense 
Oligonucleotides on L1-stimulated Axonal Elongation
Is Reversible
Hours after release from antisense treatment
01 2 2 4
Sense-treated (5 mM)
Axonal length 250 6 25 320 6 30 420 6 40
KIF4 145 6 20 140 6 25
L1 120 6 10 125 6 20
Sense-treated (5 mM) 1 L1-Fc (5 mg/ml)
Axonal length 450 6 45 580 6 60 700 6 40
KIF4 145 6 20 145 6 20
L1 120 6 10 125 6 20
ASKIF4a-treated (5 mM) 1 L1-Fc (5 mg/ml)
Axonal length 260 6 30* 380 6 40 525 6 25*
KIF4 ND* 40 6 15* 110 6 15
L1 ND* 20 6 10* 95 6 10
For this experiment the cells were treated for 48 h with the oligonucleotides starting at
the time of plating. After 1 d in vitro, 5 mg/ml of the L1-Fc chimera was added to the
culture medium. An additional pulse was given 24 h later. Cells were fixed 72 h after
plating. Each value represents the mean 6 SEM. Axonal length is expressed in mm.
KIF4 and L1 immunofluorescence were measured within the central region of axonal
growth cones as described in Table 1. Values are expressed in pixels. ND: not detect-
able.
*Values significantly different from those of the corresponding control group.The Journal of Cell Biology, Volume 149, 2000 150
with any other reported sequence, including other mem-
bers of the kinesin superfamily. In addition, none of the
S-modified antisense oligonucleotides used in this study
contains four contiguous guanosines residues, which are
believed to increase oligomer affinity to proteins and
hence generate nonspecific antisense inhibitory effects
(Morfini et al., 1997). Second, the antisense oligonucle-
otide treatment significantly reduces KIF4 protein levels
without altering the levels of several other proteins, in-
cluding tubulin, uKHC, L1, TAX-1, bgc, etc. Third, the ef-
fects of the antisense oligonucleotides are dose-dependent
and not observed when the cells are treated with equiva-
lent doses of the corresponding sense oligonucleotides. In
addition, they are also observed when the antisense oligo-
nucleotides are used at very low concentrations (2.5 mM),
a phenomenon that also contributes to rule out the possi-
bility of nonspecific binding of the oligonucleotides to pro-
teins. Fourth, the antisense treatment does not cause irre-
versible damage to the cells; hippocampal pyramidal cells
recover the normal distribution of L1 after a change to
medium free of the antisense oligonucleotide. Fifth, KIF4
suppression selectively alters L1 distribution without af-
fecting the subcellular localization of other growth cone
components such as APP or bgc, which are transported to
the neurite terminus by other microtubule-based antero-
grade motor (Ferreira et al., 1993; Morfini et al., 1997).
Conversely, the distribution of L1 is not modified by KIF2
antisense oligonucleotides, a treatment that significantly
disrupts the growth cone localization of bgc (Morfini et al.,
1997).
Several additional lines of evidence also support the
idea that KIF4 may serve as a plus-end motor involved in
the anterograde transport of L1-containing vesicles. First,
analysis of subcellular fractions obtained by SDG centrifu-
gation of microsomal fractions revealed a striking colocal-
ization of KIF4 with L1. Second, and more importantly,
immunoisolation experiments allow us to isolate the KIF4
cargo from other organelles and determine that it contains
L1 and a small amount of TAX-1. On the other hand, it
lacks uKHC, KIF2, bgc, and synaptic vesicles markers
such as synaptotagmin. Third, both KIF4 and L1 are pre-
dominantly expressed in developing brain tissue and
highly enriched in growth cone membrane preparations
obtained from fetal brain tissue. Finally, immunofluores-
cence studies show that in stage III hippocampal pyrami-
dal neurons, both proteins predominantly localize to ax-
Figure 8. KIF4 suppression
prevents L1-stimulated ax-
onal elongation. Graphs
showing the effect of the
antisense oligonucleotide
ASKIF4a (5 mM) on axonal
elongation in neurons cul-
tured in the presence or ab-
sence of the L1-Fc chimera.
For this experiment the L1-
Fc chimera (5 mg/ml) was
added to the tissue culture
medium of sense- or
ASKIF4a-treated 1-d-old
hippocampal cell cultures.
24 h later, the cells were fixed
and the length of axons and
minor neurites quantified us-
ing the morphometric menu
of the Metamorph. Groups:
Control, nontreated neurons
cultured on polylysine alone
for 2 d; Sense 1 L1-Fc chi-
mera, neurons cultured for
2 d with a sense oligonucle-
otide plus the L1-Fc chi-
mera; Antisense, neurons
cultured on polylysine alone
for 2 d in the presence of the
ASKIF4a oligonucleotide;
and Antisense 1 L1-Fc chi-
mera, neurons cultured for
2 d with the ASKIF4a oligo-
nucleotide plus the L1-Fc chi-
mera. Note that the L1-Fc
chimera selectively stimulates axonal elongation in sense-treated neurons. A similar effect was observed when the L1-Fc chimera was
added to nontreated cultures (data not shown). In contrast, the ASKIF4a oligonucleotide completely prevents this response. However,
the ASKIF4a oligonucleotide has no effect on axonal elongation in neurons, growing on polylysine alone. Each value represents the
mean 6 SEM. A total of 100 cells was analyzed for each experimental condition. Asterisks indicate values significantly different from
those of control or ASKIF4a-treated cultures.Peretti et al. KIF4 Function in Developing Neurons 151
onal shafts and their growth cones (Van den Pol and Kim,
1993; Jareb and Banker, 1998; Kamiguchi and Lemmon,
1998; this study). In this regard, it is important to note that
a small amount of both proteins exists in minor neurites of
stage III hippocampal pyramidal neurons. Although the
reasons for this are not clear at present, it is possible that
they reflect the potential of all minor neurites to become
an axon (Dotti and Banker, 1987; Esch et al., 1999) and/or
that the sorting machinery is still not fully developed in
young neurons (Bradke and Dotti, 1997).
On the other hand, it is unlikely that the preferential lo-
calization of KIF4 to axons is the result of bulk cytoplas-
mic flow. Such a mechanism has been proposed recently
for explaining a higher amount and transport of mem-
brane-bound organelles to the axon during the initial es-
tablishment of polarity (Bradke and Dotti, 1997). The pre-
dominant axonal localization of KIF4, as opposed to the
widespread distribution of uKHC, argues against bulk
flow being a major single determinant of its subcellular lo-
calization. Several additional mechanisms could account
for the axonal enrichment of KIF4 in developing neurons.
As recently discussed for KIF21B, a plus-end–directed mo-
tor enriched in dendrites (Marszalek et al., 1999), this may
include differences in protein stability between axons and
minor processes, as well as interactions between KLPs and
structural microtubule-associated proteins that may differ-
entially affect attachment/detachment of motors with mi-
crotubules (Ebneth et al., 1998; Trinczek et al., 1999). The
axonal localization of KIF4 may provide an excellent op-
portunity to examine these possibilities.
KIF4 and the Development of Neuronal Polarity
KIF4-suppressed neurons that grow on polylysine alone
extend axons that are almost identical to those of control
neurons in terms of their morphological appearance and
length (nontreated or sense-treated). Although these ob-
servations indicate that KIF4 as well as the components of
its cargo are not essentially required for axonal devel-
opment, they do not preclude a role for KIF4 in the gen-
eration of neuronal polarity. In fact, several of our
observations suggest quite the opposite. For example, the
preferential axonal localization of KIF4 and the conse-
quences of its suppression on the distribution of L1, an
early and well-established marker of axonal differentia-
tion (Van den Pol and Kim, 1993; Jareb and Banker, 1998;
this study), raise the possibility of KIF4 having a specific
and important contribution to the generation of polarity.
Thus, by transporting L1-containing vesicles to the axon,
KIF4 contributes to the establishment of a clear distinc-
tion between the axonal membrane and that of the re-
maining minor processes. Moreover, by mediating the
transport of its cargo to the axonal growth cone, KIF4
is likely to play an equally critical role in regulating the
outgrowth response of axons to growth-promoting sub-
stances, such as cell adhesion molecules. In favor of this
possibility, we have shown here that KIF4-suppressed neu-
rons are not capable of exhibiting an enhanced axonal out-
growth response when exposed to a soluble chimeric form
of the L1 glycoprotein. The most likely explanation for
such an inhibitory effect is a lack of homophilic binding of
L1 within the axonal growth cone to soluble L1 (Neu-
gebauer et al., 1988; Seilheimer and Schachner, 1988;
Doherty et al., 1995) due to a blockade of its anterograde
transport. Obviously, we cannot discard the possibility
that other as-yet unknown components of the KIF4 cargo
are also required for this response.
In any case, our results suggest a highly specialized role
for KIF4 during neuronal polarization. In this regard,
KIF4 seems to be different from other anterograde micro-
tubule-based motors mediating the transport of membra-
nous organelles in developing neurons. For example,
uKHC appears to be involved not only in the transport of
axonal proteins such as synaptophysin and GAP43 (Fer-
reira et al., 1992), but also in the trafficking of APP, a pro-
tein that first appears axonally and later localizes to the so-
matodendritic domain (Ferreira et al., 1993; Tienari et al.,
1996). In addition, and consistent with its widespread sub-
cellular localization and association with different classes
of membranous organelles (Ferreira et al., 1992; Feiguin
et al., 1994; Nakata and Hirokawa, 1995; Tanaka et al.,
1998), suppression of uKHC in cultured hippocampal py-
ramidal neurons has a general inhibitory effect on neurite
outgrowth (Ferreira et al., 1992). Other KLPs appear to
have more unique functions, but in mature neurons. Thus,
KIF1A, a microtubule-based motor that transports the
synaptic vesicle precursor to the axon, does not appear
to be essentially required for its transport during the ini-
tial establishment of neuronal polarity (Yonekawa et
al., 1998). In cultured hippocampal pyramidal neurons,
KIF1A expression increases 8 d after plating, well after
synapse formation and the consequent accumulation of
synaptic vesicle proteins. In addition, neither axonal nor
dendritic formation is impaired in cultured hippocampal
pyramidal neurons from KIF1A knockout mice. Interest-
ingly, after 8 d in culture, at which time the level of KIF1A
expression in wild-type mice increases, neuronal cell death
begins in the KIF1A mutants (Yonekawa et al., 1998). Fu-
ture studies leading to the identification of the cargo trans-
ported by other KLPs will certainly allow us a better
understanding of the transport events involved in the gen-
eration and maintenance of neuronal polarity.
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